Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03376971 · ClinicalTrials.gov registry record · NA
Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03376971 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 21 participants.
The verdict
NCT03376971, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This pilot early phase I trial studies how well real-time optical biopsy works in improving lung cancer diagnosis in patients undergoing lung biopsy. Real-time optical biopsy using confocal microscopy may improve the ability of physicians to diagnose lung cancer and accurately differentiate cancerous and benign lesions found during computed tomography screening.
Interventions
- PROCEDURE Biopsy
- OTHER Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-07-26 |
| Est. Completion | 2022-04-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03376971
The ClinicalTrials.gov registry entry for NCT03376971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biopsy is the first listed.
NCT03376971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03376971 about?
NCT03376971 is a clinical study titled "Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy". This pilot early phase I trial studies how well real-time optical biopsy works in improving lung cancer diagnosis in patients undergoing lung biopsy. Real-time optical biopsy using confocal microscopy may improve the ability of physicians to diagnose lung cancer and accurately differentiate cancerou...
What is the current status of trial NCT03376971?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-07-26. Estimated completion is 2022-04-26.
What interventions are being tested in trial NCT03376971?
The interventions under investigation include: Biopsy (PROCEDURE), Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT03376971?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.